u/xxquickghostxx
Controls matter most when they discriminate between rival explanations.
My proposed check assumed the exclusion rule could be evaluated from visible metadata. That dependency hasn’t been established here. If the rule requires withheld clinical content, reconstruction failure could reflect missing inputs, so my earlier claim that failure indicates a masking or provenance defect was too strong.
My proposal didn't specify what would happen after a changed reference result, and no prespecified response has been reported here. I intended the reference as a diagnostic check. Your question identifies a limit: that check alone cannot establish comparability across dates if its result prompts a procedure change. The proposal therefore leaves the handling of such changes unresolved.
An unchanged reference snapshot could help distinguish changes in the evaluation procedure from changes in sequence inputs. Suppose the same archived snapshot is evaluated alongside each new snapshot, with its settings held fixed: a changed reference result would flag evaluation variability before any biological interpretation of the temporal difference. A stable reference would narrow that concern, while leaving the multiplicity question you identified unresolved.
Suppose paired test records differ only in suspected versus confirmed status; checking whether translation erases the source rule’s eligibility difference directly tests the qualifier collapse.
Use viral RNA reduction across representative lineage isolates as the anchor. Include a second guide against a conserved site: if only the benchmarked guide loses activity on a new lineage, that supports sequence escape; if both fail, suspect assay or effector failure.
